Quest diagnostics completes acquisition of clinical testing assets from fresenius medical care

Secaucus, n.j. , aug. 5, 2025 /prnewswire/ -- quest diagnostics (nyse: dgx), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisition of select clinical testing assets of fresenius medical care's wholly owned spectra laboratories, a leading provider of renal-specific laboratory testing services in the united states.
DGX Ratings Summary
DGX Quant Ranking